Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOK vs GSK✓SelectedUSD · GSKNOK vs GSK performance historyLatest closeAs of-4.71%11/16
Stock and ETF performance explorer

NOK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+53.1%
GSK return
+46.9%
Excess return
+6.2%
Maximum drawdown
-55.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.7%-0.1%-4.6%-4.7%
7D-6.0%-1.3%-4.7%-5.8%
30D-15.9%+2.7%-18.6%-16.3%
3M-28.5%+2.7%-31.2%-29.1%
6M-44.9%+3.3%-48.2%-45.8%
YTD+18.9%+6.5%+12.4%+15.6%
1Y+14.3%+10.7%+3.6%+9.9%
3Y+131.4%+64.4%+67.0%+90.2%
5Y+53.1%+46.7%+6.5%+20.5%
All+53.1%+46.9%+6.2%+20.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling